Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr
News

Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr

Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023

  • By IPP Bureau | October 21, 2023

Aarti Drugs Limited has reported Consolidated financial results for the period ended September 30, 2023.

Aarti Drugs has posted net profit of Rs. 39.59 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 47.85 crores for the period ended June 30, 2023. It posted net profit of Rs.38.75 crores for the period ended September 30, 2022.

Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023 as compared to Rs. 661.71 crores during the period ended June 30, 2023. It reported total income of Rs.687.78 crores during the period ended September 30, 2022.

For the Half Year ended Sept 30, 2023, Aarti Drugs has reported total income of Rs.1303.93 crores as compared to Rs.1310 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit of Rs.87.44 crores for the 6 Months period ended September 30, 2023 as against net profit of Rs.73.54 crores for the 6 Months period ended September 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization